In this context, SPP1+ macrophages emerge as key immunosuppressive actors during glioma progression, being implicated in tumour progression and invasion, partly through their association with extracellular matrix remodelling factors like cathepsins, shaping an immunosuppressive tumour microenvironment, and correlating with decreased overall survival. The gene discussed is SPP1; the disease is central nervous system cancer.